Joachim Jankowski

Professor Joachim Jankowski is a distinguished researcher at RWTH Aachen University's Faculty of Medicine, where he leads investigations at the Institute for Molecular Cardiovascular Research (IMCAR). His work bridges nephrology and cardiology, focusing on the molecular mechanisms underlying the cardiovascular complications of chronic kidney disease. As principal investigator of the SFB/TRR219 Research Centre, he coordinates a major collaborative effort examining cardio-renal interactions.

Dr. Jankowski's research interests center on uremic toxins, vascular calcification, and post-translational modifications in chronic kidney disease. His laboratory employs advanced proteomic and metabolomic approaches to identify novel biomarkers and therapeutic targets. His work has significantly advanced understanding of how kidney dysfunction drives cardiovascular pathology through molecular pathways including carbamylation, guanidinylation, and other protein modifications.

Analysis of his recent publications reveals a strong focus on translational research with immediate clinical implications. His team has made important contributions to understanding vascular calcification mechanisms, identifying novel uremic toxins, and developing potential therapeutic interventions targeting cardio-renal syndrome. His research increasingly incorporates big data analytics and precision medicine approaches to improve patient stratification and treatment selection.

Professor Jankowski maintains extensive national and international collaborations, particularly with European research groups in nephrology and cardiology. His work has established important connections between basic molecular mechanisms and clinical outcomes in patients with kidney and cardiovascular diseases.